CDIO
CDIO
NASDAQ · Biotechnology

Cardio Diagnostics Holdings

$1.29
+0.24 (+22.86%)
As of Feb 8, 2:34 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,460.5% upside
Low Target $21.42
Average Target $33.03
High Target $37.66
Current Price $1.29
Current
$1.29
Target
$33.03
$21.42 $33.03 avg $37.66
Scenario Analysis
Bear Case
$21.42
1,560.5%
Low target
Base Case
$33.03
+2,460.5%
Avg target
Bull Case
$37.66
+2,819.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$35.54
-96.4% from high
52-Week Low
$20.25
+-93.6% from low
Target vs 52W High
$33.03
-7.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%